EyePod - 37 - COVID-19 special - Covid-19 Guidelines from Vision Academy with Monica Lövestam-Adrian

Welcome to another Covid-19 special episode of EyePod Bayer!Today we are going to discuss how the current situation can affect treatment of patients with intravitreal injections and we will refer to a recently published paper in Graefe's Archive for Clinical and Experimental Ophthalmology: Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. This paper was authored by the network Vision Academy, sponsored by Bayer, which is an international group of retinal experts who collaborate to share existing skills and knowledge in retinal diseases.The recommendations published in the paper were developed during a virtual meeting in March 2020 by the 14-member-Vision Academy Steering Committee. Already available guidance documents for patients receiving intravitreal injections of anti-VEGF agents during the COVID-19 pandemic were reviewed, debated and summarized in the paper. In only 18 days the manuscript was finalized, submitted and accepted for publication, which probably makes it one of the fastest publications in history!In this episode, we are honored to have Monica Lövestam-Adrian, Head of the Medical Retina Department at Lund University Hospital and Associate Professor in Ophthalmology at Lund University in Sweden. Monica is one of the members in the Vision Academy Steering Committee and will share her insights of the guidelines with us today. For contact:[email protected] MA-EYL-DK-0127-1 Hosted on Acast. See acast.com/privacy for more information.